SCHEMBL6045696

SCHEMBL6045696

CC(O[C@H]1C=C[C@H](O)C1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6045517 1.00
SCHEMBL6045522 0.77 SMN1; SMN2 (0.34)
SCHEMBL6045477 0.77 SMN1; SMN2 (0.34)
SCHEMBL15044657 0.70
SCHEMBL9599191 0.69
SCHEMBL10416584 0.69
SCHEMBL25475515 0.68 MAPK1 (0.32)
SCHEMBL307800 0.68 CA12 (0.38)
SCHEMBL6045764 0.68 GABRA1 (0.31)
SCHEMBL6045532 0.68 GABRA1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252774-A1 Regulation of type 5 adenylyl cyclase for treatment of neurodegenerative and cardiac diseases NEW JERSEY, UNIVERSITY OF MEDICINE AND DENTISTRY OF 2006-11-09 US disclosed